How oxygen therapy improves cord blood transplants
Leslie Orr-Rochester
A small clinical trial—the first human trial of its kind—has uncovered the importance of a hormone called erythropoietin for effective umbilical cord blood transplants in leukemia and lymphoma patients.
Lowering EPO levels in people aids in a process known as homing, where newly transplanted blood stem cells migrate properly to the bone marrow of the patient and begin to restore the body’s ability to make healthy blood and immune cells.
The findings appear in the journal Blood. An accompanying..